Background Triple-negative breast cancer (TNBC) is a heterogeneous disease and we have
previously shown that rapid relapse of TNBC is associated with distinct sociodemographic …

Background Triple-negative breast cancer (TNBC) patients who recur at different times are
associated with distinct biological characteristics and prognoses. Research on rapid-relapse …

Background: Triple-negative breast cancer (TNBC) accounts for disproportionately poor
outcomes in breast cancer, driven by a subset of rapid-relapse TNBC (rrTNBC) with marked …

Purpose Triple-negative breast cancer (TNBC) is a highly heterogeneous disease. Patients
with early-stage TNBCs have distinct likelihood of distant recurrence. This study aimed to …

Purpose: Triple-negative breast cancer (TNBC) is a molecularly complex and
heterogeneous breast cancer subtype with distinct biological features and clinical behavior …

Purpose: Emerging data suggest immune checkpoint inhibitors have reduced efficacy in
heavily pretreated triple-negative breast cancers (TNBC), but underlying mechanisms are …

Simple Summary Epidemiologic studies have observed higher risks of breast cancer
recurrence and death in women diagnosed< 40 years of age compared to≥ 40 years. There …

Purpose Immune checkpoint blockade (ICB) therapy has transformed the treatment of triple-
negative breast cancer (TNBC) in recent years. However, some TNBC patients with high …

Triple-negative breast cancer (TNBC) is an aggressive subtype characterized by extensive
intra-tumoral heterogeneity, and frequently develops resistance to therapies. Tumor …

Background Triple-negative breast cancer (TNBC) represents about 19% of all breast
cancer cases in the Chinese population. Lack of targeted therapy contributes to the poorer …